MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug aims to slow blinding disease
Disease control OngoingThis study tests a new medicine called AVD-104 for people with geographic atrophy, a late stage of age-related macular degeneration that causes blind spots. The goal is to see if the drug is safe and can slow the growth of these spots. About 300 participants will receive injectio…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
New eye implant could reduce needle sticks for wet AMD patients
Disease control OngoingThis study tests a new drug called zifibancimig for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The drug is given as an eye injection or through a small implant in the eye to deliver medicine continuously. The goal is to see if it is sa…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 10:22 UTC
-
Healthy volunteers shed light on vision training for macular degeneration
Knowledge-focused OngoingThis study looks at how the brain changes and adapts after losing central vision, which happens in conditions like macular degeneration. Researchers will test healthy adults aged 18-30 to understand how training can improve visual skills. The goal is to use these insights to deve…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 10:24 UTC